Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Site × trametinib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 4 Multiple Myeloma 4 Hematologic Neoplasms 4 Lymphoma 3 Brain Neoplasms 3 Biliary Tract Neoplasms 3 Skin Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioma 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurofibromatosis 1 1 Neurocytoma 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Hairy Cell 1 Klatskin Tumor 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 pembrolizumab 3 napabucasin 3 Paclitaxel 3 Irinotecan 3 pralsetinib 2 patritumab 2 Standard of Care 2 Pemetrexed 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Ascorbic Acid 2 Albumin-Bound Paclitaxel 2 valrubicin 1 sotorasib 1 selpercatinib 1 ribociclib 1 relatlimab 1 pamiparib 1 osimertinib 1 ipatasertib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 alectinib 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡